Genes, environment, and cardiovascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 7, 2003, Pages 1190-1196

  Sing, Charles F ^a   Stengård, Jari H ^a,c   Kardia, Sharon L R ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; CAUSALITY; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME, HUMAN; GENOTYPE; HUMANS; MODELS, GENETIC;

EID: 0038785683     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000075081.51227.86     Document Type: Review

References (57)

1. Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988;42:677-693.
2. Baird PA. Genetics and health care: a paradigm shift. Perspect Biol Med. 1990;33:203-213.
3. Strohman RC. Ancient genomes, wise bodies, unhealthy people: limits of a genetic paradigm in biology and medicine. Perspect Biol Med. 1993;37:112-145.
4. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269-1276.
5. American Heart Association. Heart and stroke facts: 1994 statistical supplement. Dallas, Tex: American Heart Association; 1994.
6. American Heart Association. Heart and stroke facts. Dallas, Tex: American Heart Association; 2002.
7. American Heart Association. Heart and stroke statistical update. Dallas, Tex: American Heart Association; 2002b
8. Davignon J, DuFour R, Cantin M. Hypertension: Physiopathology and Treatment. 2nd ed. New York, NY: Mc Graw-Hill Book Co; 1983:810-852.
9. Sing CF, Moll PP. Genetics of atherosclerosis. Annu Rev Genet. 1990;24:171-187.
10. Sing CF, Haviland MB, Templeton AR, Zerba KE, Reilly SL. Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease. Ann Med. 1992;24:539-547.
11. Sing CF, Reilly SL. Genetics of common diseases that aggregate, but do not segregate, in families. In: Sing CF, Hanis CL, eds. Genetics of Cellular, Individual, Family, and Population Variability. New York, NY: Oxford University Press; 1993:140-161.
12. Sing CF, Zerba KE, Reilly SL. Traversing the biological complexity in the hierarchy between genome and CAD endpoints in the population at large. Clin Genet. 1994;46:6-14.
13. Strohman RC. Epigenesis: the missing beat in biotechnology? Biotechnology. 1994;12:156-164.
14. Sing CF, Haviland MB, Templeton AR, Reilly SL. Alternative genetic strategies for predicting risk of atherosclerosis. In: Woodford FP, Davignon J, Sniderman AD, eds. Atherosclerosis X, vol 10. Amsterdam, Netherlands: Elsevier Science Publishers BV; Excerpta Medica International Congress Series, 1995:638-644.
15. Sing CF, Haviland MB, Reilly SL. Genetic architecture of common multifactorial diseases. In: Chadwick DJ, Cardew G, eds. Variation in the Human Genome (Ciba Foundation Symposium 197). Chichester, UK: John Wiley and Sons; 1996:211-232.
16. Strohman RC. Maneuvering in the complex path from genotype to phenotype. Science. 2002;296:701-703.
17. Dennis C. Altered states. Nature. 2003;42:686-688.
18. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645.
19. Zerba KE, Sing CF. The role of genome type-environment interaction and time in understanding the impact of genetic polymorphisms on lipid metabolism. Curr Opin Lipidol. 1993;4:152-162.
20. Zerba KE, Ferrell RE, Sing CF. Genotype-environment interaction: apolipoprotein E (Apo E) gene effects and age as an index of time and spatial context in the human. Genetics. 1996;143:463-478.
21. Zerba KE, Ferrell RE, Sing CF. Complex adaptive systems and human health: the influence of common genotypes of the apolipoprotein E (ApoE) gene polymorphism and age on the relational order within a field of lipid metabolism traits. Hum Genet. 2000;107:466-475.
22. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
23. Rose S. Lifelines: Biology Beyond Determinism. New York, NY: Oxford University Press; 1997.
24. Lewontin RC. The Triple Helix: Gene, Organism, and Environment. Cambridge, Mass: Harvard University Press; 2000.
25. Davidson EH, McClay DR, Hood L. Regulatory gene networks and the properties of the developmental process. Proc Natl Acad Sci U S A. 2003;100:1475-1480.
26. Scriver CR, Byck S, Prevost L, Hoang L. PAH mutation analysis consortium. In: Chadwick DJ, Cardew G, eds. Variation in the Human Genome (Ciba Foundation Symposium 197). Chichester, UK: John Wiley and Sons; 1996:73-96.
27. Weatherall D. The genetics of common diseases: the implications of population variability In: Chadwick DJ, Cardew G, eds. Variation in the Human Genome (Ciba Foundation Symposium 197). Chichester, UK: John Wiley and Sons; 1996:300-311.
28. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengård J, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. Haplotype structure and population genetic inferences from nucleotide sequence variation in human lipoprotein lipase. Am J Hum Genet. 1998;63:595-612.
29. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengård JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67:881-900.
30. Stengård JH, Clark AG, Weiss KM, Kardia S, Nickerson DA, Salomaa V, Ehnholm C, Boerwinkle E, Sing CF. Contributions of 18 additional DNA sequence variations in the gene for apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet. 2002;71:501-517.
31. Golub ES. The Limits of Medicine: How Science Shapes Our Hope for the Care. New York, NY: Times Books; 1994.
32. Salthe SN. Evolving Hierarchical Systems: Their Structure and Representation. New York, NY: Columbia University Press; 1993.
33. Nelson MR, Kardia SLR, Ferrell RE, Sing CF. A combinatorial partitioning method (CPM) to identify multilocus genotypic classes that predict quantitative trait variation. Genome Res. 2001;11:458-470.
34. Chakravarti A, Little P. Nature, nurture and human disease. Nature. 2003;421:412-414.
35. Morton NE. Genetic epidemiology. Annu Rev Genet. 1993;27:523-538.
36. Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet. 1990;24:133-170.
37. Davignon J. New Horizons in Coronary Heart Disease. London, UK: Current Science; 1993:1-21.
38. Morin E. Method: Towards a Study of Human Kind: The Nature of Nature (American University Studies Vol 111). New York, NY: Peter Lang Publishing; 1992.
39. Cohen J, Rice SH. Integrative Approaches to Molecular Biology. Cambridge, Mass: MIT Press; 1995.
40. Popper KR. A World of Propensities. Bristol, UK: Thoemmes Press; 1995.
41. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33:228-237.
42. Morowitz H. Phenetics: a born again science. Complexity. 2003;8:12-13.
43. Schuster H. High risk/high priority: familial hypercholesterolemia: a paradigm for molecular medicine. Atherosclerosis. 2002;2:27-32.
44. Goodwin B. How the Leopard Changed Its Spots. New York, NY: Scribner; 1994.
45. Sole RV, Goodwin B. Signs of Life: How Complexity Pervades Biology. New York, NY: Basic Books; 2001.
46. Somogyi R, Greller LD. The dynamics of molecular networks: applications to therapeutic discovery. Drug Discov Today. 2001;6:1267-1277.
47. Lewontin RC. Genotype and phenotype. In: Keller EF, EA Lloyd, eds. Keywords in Evolutionary Biology. Cambridge, Mass: Harvard University Press; 1992:137-144.
48. Nickerson DA, Taylor S, Fullerton SM, Weiss KM, Clark AG, Stengård J, Salomaa V, Boerwinkle E, Sing CF. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 2002;10:1532-1545.
49. Kardia SLR, Haviland MB, Ferrell RE, Sing CF. The relationship between risk factor levels and presence of coronary artery calcification is dependent on Apolipoprotein E genotype. Arterioscler Thromb Vasc Biol. 1999;19:427-435.
50. Stengård JH, Kardia SL, Tervahauta M, Ehnholm C, Nissinen A, Sing CF. Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residence. Clin Genet. 1999;56:367-377.
51. Fan J, Yang X, Wang W, Wood WH 3rd, Becker KG, Gorospe M. Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc Natl Acad Sci USA. 2002;99:10611-10616.
52. Anderson PW. More is different: broken symmetry and the nature of the hierarchical structure of science. Science. 1972;177:393-396.
53. Anderson PW. Complexity: Metaphors, Models, and Reality (Santa Fe Institute Studies of Complexity, vol 19). Reading, Mass: Addison Wesley; 1994.
54. Barrow JD. Theories of Everything: the Quest for Ultimate Explanation. New York, NY: Oxford University Press; 1991.
55. Laughlin RB, Pines D. The theory of everything. Proc Natl Acad Sci USA. 2000;97:28-31.
56. Hoffmann R. Why buy that theory. Am Sci. 2003;91:9-11.
57. Kardia SLR, Haviland MB, Sing CF. Correlates of family history of coronary artery disease in children. J Clin Epidemiol. 1998;51:473-486.